Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
The growing body of evidence supporting the therapeutic efficacy of psychoactive substances, like psilocybin, has driven significant interest in recent decades due to their low toxicity and potential applications in treating various mental health disorders. However, producing pharmaceutical-grade psilocybin remains challenging, with three primary approaches: chemical synthesis, biosynthesis, and extraction from Psilocybe mushroom fruiting bodies. This systematic review evaluates the extraction and quantification methods for psilocybin and psilocin, aiming to contribute to the development of standardized protocols that ensure compound quality and purity. A total of 25 relevant studies were selected from an initial pool of 9152 publications indexed in platforms such as Scopus, ScienceDirect, Web of Science, and PubMed. The findings indicate that both the extraction method and the choice of mushroom species significantly influence compound yields. Ultrasonic bath extraction was identified as the most efficient technique, particularly for species including Psilocybe cyanescens and Psilocybe cubensis. High-performance liquid chromatography (HPLC) was the most-used method for identifying and quantifying these compounds. Furthermore, polar solvents were critical for effective solubilization, with parameters such as temperature, solvent-to-material ratio, and extraction time playing key roles in optimizing yields. This review serves as a key scientific reference for advancing research, enhancing analytical precision, and ensuring reproducibility through the standardization of extraction and quantification protocols.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Flow diagram of the literature search and selection criteria from PRISMA [43].](https://figures.cochat.ai/paper-figures/efe3d68ca30b4a92ae024217b232c9d3/extraction-yields-of-psilocybin-and-psilocin-a-short-review-of-current-methods-figure-1.jpg)

![Figure 3 Overall quality of the selected studies [35,40,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66]. A detailed description of the evaluated parameters can be found in Table A3.](https://figures.cochat.ai/paper-figures/1d3dbd67c3f740bc84b968aca813dce0/extraction-yields-of-psilocybin-and-psilocin-a-short-review-of-current-methods-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
Methley, A. M., Campbell, S., Chew-Graham, C., McNally, R., & Cheraghi-Sohi, S. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0579-0 · Cited by 2,706
Methodological quality of case series studies: an introduction to the JBI critical appraisal tool
Munn, Z., Barker, T. H., Moola, S., Tufanaru, C., Stern, C., McArthur, A., Stephenson, M., & Aromataris, E. (2019) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-d-19-00099 · Cited by 1,581
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Kaufmann, B., & Christen, P. (2002) · Phytochemical Analysis · doi:10.1002/pca.631 · Cited by 831 · cited 1×
“We accept articles with only psilocybin or psilocin.”
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789
Homological scaffolds of brain functional networks
Petri, G., Expert, P., Turkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P. J., & Vaccarino, F. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0873 · Cited by 675
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587
Ultrasound-Assisted Extraction of Natural Products
Esclapez, M. D., García-Pérez, J. V., Mulet, A., & Cárcel, J. A. (2011) · Food Engineering Reviews · doi:10.1007/s12393-011-9036-6 · Cited by 472
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
Potential Therapeutic Effects of Psilocybin
Johnson, M. W., & Griffiths, R. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0542-y · Cited by 296
Classical psychedelics for the treatment of depression and anxiety: A systematic review
Muttoni, S., Ardissino, M., & John, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.076 · Cited by 256 · cited 1×
“…and tobacco addiction [3], major depressive disorder (MDD) and treatment-resistant depression (TRD) [4–6], end-of-life depression and anxiety [7,8], post-traumatic stress disorder (PTSD) [9], obsessive–compulsive disorder (OCD) [10,11], eating disorders like anorexia nervosa [12], and other…”
The Therapeutic Potential of Psilocybin
Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 242
Mertens, L. J., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D. J., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119895520 · Cited by 208
Psychedelic Drug Legislative Reform and Legalization in the US
Siegel, J. S., Daily, J. E., Perry, D. A., & Nicol, G. E. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4101 · Cited by 179
Therapeutic effect of psilocybin in addiction: A systematic review
van der Meer, P. B., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., de Waal, M. M., Goudriaan, A. E., Kramers, K., Schellekens, A., Somers, M., Bossong, M. G., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1134454 · Cited by 127 · cited 1×
“These include alcohol and tobacco addiction [3], major depressive disorder (MDD) and treatment-resistant depression (TRD) [4–6], end-of-life depression and anxiety [7,8], post-traumatic stress disorder (PTSD) [9], obsessive–compulsive disorder (OCD) [10,11], eating disorders like anorexia nervosa…”
Horizontal gene cluster transfer increased hallucinogenic mushroom diversity
Reynolds, H. T., Vijayakumar, V., Gluck-Thaler, E., Korotkin, H. B., Matheny, P. B., & Slot, J. C. (2018) · Evolution Letters · doi:10.1002/evl3.42 · Cited by 111
Van Court, R. C., Wiseman, M. S., Meyer, K. W., Ballhorn, D. J., Amses, K. R., Slot, J. C., Dentinger, B. T. M., Garibay-Orijel, R., & Uehling, J. K. (2022) · Fungal Biology · doi:10.1016/j.funbio.2022.01.003 · Cited by 94
Dose–response relationships of psilocybin-induced subjective experiences in humans
Hirschfeld, T., & Schmidt, T. T. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121992676 · Cited by 93
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Tylš, F., Páleníček, T., Kadeřábek, L., Lipski, M., Kubešová, A., & Horáček, J. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000198 · Cited by 86
Nkadimeng, S. M., Steinmann, C. M., & Eloff, J. N. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s317182 · Cited by 83
Psilocybin and MDMA for the treatment of trauma-related psychopathology
Bird, C. I. V., Modlin, N. L., & Rucker, J. J. H. (2021) · International Review of Psychiatry · doi:10.1080/09540261.2021.1919062 · Cited by 80
Morphological and chemical analysis of magic mushrooms in Japan
Tsujikawa, K., Kanamori, T., Iwata, Y. T., Ohmae, Y., Sugita, R., Inoue, H., & Kishi, T. (2003) · Forensic Science International · doi:10.1016/j.forsciint.2003.08.009 · Cited by 78
Mußhoff, F., Madea, B., & Beike, J. (2000) · Forensic Science International · doi:10.1016/s0379-0738(00)00211-5 · Cited by 77
Luppi, A. I., Hansen, J. Y., Ram, A., Carhart-Harris, R. L., Roseman, L., Timmermann, C., Golkowski, D., Ranft, A., Ilg, R., Jordan, D., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8332 · Cited by 75
Smausz, R., Neill, J. C., & Gigg, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092508 · Cited by 70
Beug, M. W., & Bigwood, J. (1982) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(82)90013-7 · Cited by 65
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes
Matzopoulos, R., Morlock, R., Morlock, A., Lerer, B., & Lerer, L. B. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.780696 · Cited by 65
Zhuk, O., Jasicka-Misiak, I., Poliwoda, A., Kazakova, A., Godovan, V., Halama, M., & Wieczorek, P. (2015) · Toxins · doi:10.3390/toxins7041018 · Cited by 62
Green extraction techniques in green analytical chemistry: A 2019–2023 up-date
Esteve-Turrillas, F. A., Garrigues, S., & de la Guárdia, M. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117464 · Cited by 59
How ecstasy and psilocybin are shaking up psychiatry
Tullis, P. (2021) · Nature · doi:10.1038/d41586-021-00187-9 · Cited by 58
Laussmann, T., & Meier-Giebing, S. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2009.12.013 · Cited by 56
Kolaczynska, K. E., Liechti, M. E., & Duthaler, U. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122486 · Cited by 56
Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids
Gotvaldová, K., Borovička, J., Hájková, K., Cihlářová, P., Rockefeller, A., & Kuchař, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214068 · Cited by 53
Beug, M. W., & Bigwood, J. (1981) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)88741-5 · Cited by 52
Keller, T., Schneider, A., Regenscheit, P., Dirnhofer, R., Rücker, T., Jaspers, J., & Kisser, W. (1999) · Forensic Science International · doi:10.1016/s0379-0738(98)00168-6 · Cited by 51
Anastos, N., Lewis, S. W., Barnett, N. W., & Sims, D. N. (2006) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2005.00033.x · Cited by 44
Bigwood, J., & Beug, M. W. (1982) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(82)90014-9 · Cited by 42
Wurst, M., Semerdžieva, M., & Vokoun, J. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)99190-3 · Cited by 39
Genetic Survey of Psilocybe Natural Products
Dörner, S., Rogge, K., Fricke, J., Schäfer, T., Wurlitzer, J. M., Gressler, M., Pham, D. N. K., Manke, D. R., Chadeayne, A. R., & Hoffmeister, D. (2022) · ChemBioChem · doi:10.1002/cbic.202200249 · Cited by 39
Psilocybin in Palliative Care: An Update
Whinkin, E., Opalka, M., Watters, C., Jaffe, A., & Aggarwal, S. K. (2023) · Current Geriatrics Reports · doi:10.1007/s13670-023-00383-7 · Cited by 39
Goff, R., Smith, M., Islam, S., Sisley, S., Ferguson, J., Kuzdzal, S., Badal, S., Kumar, A. B., Sreenivasan, U., & Schug, K. A. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.342161 · Cited by 36
Saito, K., Toyo’oka, T., Kato, M., Fukushima, T., Shirota, O., & Goda, Y. (2005) · Talanta · doi:10.1016/j.talanta.2004.11.031 · Cited by 34
Strauss, D., Ghosh, S. B., Murray, Z., & Gryzenhout, M. (2022) · Frontiers in Forests and Global Change · doi:10.3389/ffgc.2022.813998 · Cited by 33
Anastos, N., Barnett, N. W., Lewis, S. W., Gathergood, N., Scammells, P. J., & SIMS, D. (2005) · Talanta · doi:10.1016/j.talanta.2004.11.038 · Cited by 32
Baeocystin in Psilocybe semilanceata
Repke, D. B., & Leslie, D. T. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660130 · Cited by 31
Long-term effects of depression treatment
Uher, R., & Pavlová, B. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00578-7 · Cited by 31
GLC-Mass Spectral Analysis of Psilocin and Psilocybin
Repke, D. B., Leslie, D. T., Mandell, D., & Kish, N. G. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660539 · Cited by 30
Psilocybin for the Treatment of Obsessive-Compulsive Disorders
Ehrmann, K., Allen, J. J. B., & Moreno, F. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_279 · Cited by 30
Bradshaw, A. J., Backman, T. A., Ramírez-Cruz, V., Forrister, D. L., Winter, J. M., Guzmán-Dávalos, L., Furci, G., Stamets, P., & Dentinger, B. T. M. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01498-22 · Cited by 29
Gattuso, J. J., Wilson, C., Hannan, A. J., & Renoir, T. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16017 · Cited by 28
Magic truffles or Philosopher's stones: a legal way to sell psilocybin?
Pellegrini, M., Rotolo, M. C., Marchei, E., Pacifici, R., Saggio, F., & Pichini, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1400 · Cited by 25
Patents on Psychedelics: The Next Legal Battlefront of Drug DevelopmentPreprint
Marks, M., & Cohen, I. G. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3948757 · Cited by 25
Raithatha, S. A., Hagel, J. M., Matinkhoo, K., Yu, L. X., Press, D., Cook, S. G., Sharma, G., Dhananjaya, D., Jensen, G., Lee, J. B., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01225 · Cited by 24
Is it now time to prepare psychiatry for a psychedelic future?
Nutt, D., CROME, I. B., & Young, A. H. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.76 · Cited by 20
Gambaro, V., Roda, G., Visconti, G. L., Arnoldi, S., Casagni, E., Dell’Acqua, L., Farè, F., Paladino, E., Rusconi, C., Arioli, S., et al. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.03.043 · Cited by 18
Shi, Y., Wang, R., Yuan, S., Qiang, H., Shen, M., Shen, B., Drummer, O. H., Yu, Z., Zhao, Y., & Xiang, P. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122392 · Cited by 17
Indole derivatives in certain Panaeolus species from East Europe and Siberia
Gurevich, L. S. (1993) · Mycological Research · doi:10.1016/s0953-7562(09)80249-9 · Cited by 14
Koçak, A., Cotiis, L. M. D., & Hoffman, D. B. (2009) · Forensic Science International · doi:10.1016/j.forsciint.2009.11.002 · Cited by 13
Detection of Psilocybin and Psilocin in Norwegian Species ofPluteusandConocybe
Christiansen, A., Rasmussen, K. E., & Høiland, K. (1984) · Planta Medica · doi:10.1055/s-2007-969726 · Cited by 13
Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds
Waldbillig, A., Baranova, M., Neumann, S., Andrade, J., & Sidhu, S. (2023) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2023.1295223 · Cited by 13
Cultivation, chemistry, and genome of Psilocybe zapotecorum
Miller, D. R., Jacobs, J., Rockefeller, A., Singer, H., B., I. M., Conway, J., Slot, J. C., & Cliffel, D. E. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00332 · Cited by 12
[Levels of psilocybin and psilocin in various types of mushrooms].
Stříbrný, J., Borovička, J., & Sokol, M. (2003) · PubMed · Cited by 11
Horizontal gene cluster transfer increased hallucinogenic mushroom diversityPreprint
Reynolds, H. T., Vijayakumar, V., Gluck‐Thaler, E., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/176347 · Cited by 9
Rafati, H., Riahi, H., & Mohammadi, A. (2009) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushr.v11.i4.80 · Cited by 8
Lanthanum trilactate: Vibrational spectroscopic study − infrared/Raman spectroscopy
Švecová, M., Novák, V., Bartůněk, V., & Člupek, M. (2016) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2016.09.020 · Cited by 6
Musikaphongsakul, P., Ya, K., Subsoontorn, P., & Lohitnavy, M. (2021) · F1000Research · doi:10.12688/f1000research.28133.1 · Cited by 6
Cardoso, M. S., da Cunha, K. F., Silva, I. G., Fiorentin, T. R., de Campos, E. G., & Costa, J. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad064 · Cited by 4
Yao, Y., Zhang, Y., Liang, J., Liu, F., Li, Z., Li, H.-J., & Xu, F. (2024) · Toxicon · doi:10.1016/j.toxicon.2024.107849 · Cited by 4
Supercritical Fluid Extraction of Natural Products: A Review
Khanam, S. (2014) · Cited by 3
Rapid quantification of Psilocybin with reversed-phase HPLC and single-wavelength detectionPreprint
Samuelsson, A., Janusson, E., Shah, S., & Roggen, M. (2021) · ChemRxiv · doi:10.26434/chemrxiv-2021-70mm1 · Cited by 2
Psilocybin Mushrooms of the World: an identification guide. Paul Stamets.
Rutter, G. A. (2010) · Edinburgh Journal of Botany · doi:10.1017/s0960428600001426 · Cited by 1
Therapeutic Implications of Psilocybin in the Wake of Decriminalization
Lash, N., Tadros, G., & Tadros, E. (2024) · Integrative and Complementary Therapies · doi:10.1089/ict.2024.27206.nl · Cited by 1
Pholiotina cyanopus, a rare fungus producing psychoactive tryptamines
Halama, M., Poliwoda, A., Jasicka-Misiak, І., et al. (2014) · Open Life Sciences · doi:10.1515/biol-2015-0005
Research works printed but not linked: 2
- PubMed (2025, January 13). Psychedelics, Available online: https://pubmed.ncbi.nlm.nih.gov/?term=psychedelics&timeline=expanded.
- Qi, 2022, A preliminary study on chemical components of the hallucinogenic poisonous mushroom Psilocybe ovoideocystidiata, Mycosystema, 41, 1704
Cited by
Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives
da Luz, M. A., Guedes, H. V. S., Bisneto, A. B. M., de Jesus, R. A., Galdino, T. P., de Oliveira, L. C., Afonso, V. I., Fook, M. V. L., de Lima, A. G. B., Silva, S. M. D. L., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18070989 · Cited by 8
Self-citationGaldino, T. P., de Oliveira, L. C., da Luz, M. A., Barbosa, R. C., Torres, M. D. C. D. M., Sivieri, K., Fernandes, P. A., dos Santos, M. L., de Lima, A. G. B., Silva, S. M. D. L., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c02751 · Cited by 7
Self-citationGaldino, T. P., Bisneto, A. B. M., Pedro, M. D. S., de Oliveira, L. C., da Luz, M. A., de Lima, A. G. B., Silva, S. M. D. L., & Fook, M. V. L. (2025) · ACS Omega · doi:10.1021/acsomega.5c05606 · Cited by 4
Self-citationEkoh, F., Rerrie, S., Angud, J., & Mirabelli, E. (2025) · Psychoactives · doi:10.3390/psychoactives4040039 · Cited by 4
Sharchaton, A., Parsha, S., Azerrad, S. P., Dekel, Y., Rabah, N., Páleníček, T., & Kurzbaum, E. (2026) · Journal of Fungi · doi:10.3390/jof12070486 · Cited by 1
Metadata
- Authors
- Galdino, T. P., Oliveira, L. C., Luz, M. A., Jesus, R. A., Lima, E. P. N., Torres, M. C. M., Sivieri, K., Afonso, V. I., Delgado, J. M. P. Q., Lima, A. G. B., Silva, S. M. L., & Fook, M. V. L.
- Affiliations
- Universidade Federal de Campina Grande (BR)
- Department of Chemistry, State University of Paraíba, Campina Grande 58429-500, Brazil
- Departament of Food and Nutrition, Faculty of Pharmaceutical Sciences, Sao Paulo State University, Araraquara 14800-903, Brazil
- Universidade do Porto (PT)
- Mechanical Engineering Department, Federal University of Campina Grande, Campina Grande 58429-900, Brazil
- Northeast Biomaterials Evaluation and Development Laboratory, CERTBIO, Academic Unit of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil
- Corresponding author
- Delgado, João M. P. Q.
- Fook, Marcus V. L.
- ORCID
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2025-03-07
- Volume
- 18
- Issue
- 3
- Pages
- 380
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC11945839
- OpenAlex
- W4408226956
- Cited by
- 12
- References
- 74
- Citations by year
- 2026: 6 · 2025: 6
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
- Keywords
- psilocybin, psilocin, extraction yield, Psilocybe, mushroom fruiting bodies, HPLC determination, polar solvents, Psilocybe cubensis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.